ENDOXAN 50 mg, coated tablet 50 tablets
Active ingredients: Cyclophosphamide hydrate, Anhydrous cyclophosphamide hydrate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Coated tablet50 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ENDOXAN 50 mg, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 50 comprimé(s)
- Marketing authorisation holder
- BAXTER
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Sept 1960
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62554177CIP73035890CIP133400930358900Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CYCLOPHOSPHAMIDEcomprimé | 53,5 mg · un comprimé | SA |
| CYCLOPHOSPHAMIDE ANHYDREcomprimé | 50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.